NON-MALIGNANT DISORDERS
Clinical trials for NON-MALIGNANT DISORDERS explained in plain language.
Never miss a new study
Get alerted when new NON-MALIGNANT DISORDERS trials appear
Sign up with your email to follow new studies for NON-MALIGNANT DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New bone marrow transplant trial offers hope for children with severe blood disorders
Disease control Recruiting nowThis study tests a bone marrow transplant from a partially matched family donor for children under 21 with severe non-cancer diseases like sickle cell disease, bone marrow failure, or immune disorders. The goal is to see if the transplant can safely replace the diseased bone marr…
Matched conditions: NON-MALIGNANT DISORDERS
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 05:41 UTC
-
Milder transplant approach aims to tame deadly immune diseases
Disease control Recruiting nowThis study tests a less intense stem cell transplant for people with non-cancerous blood, immune, or metabolic disorders. The goal is to see if a milder pre-transplant treatment can help donor cells take hold with fewer severe side effects. About 220 participants will be followed…
Matched conditions: NON-MALIGNANT DISORDERS
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Personalized dosing may reduce transplant side effects in kids
Knowledge-focused Recruiting nowThis study looks at how the drug treosulfan is processed in children getting stem cell transplants. The goal is to find the right dose for each child to reduce side effects and improve outcomes. About 70 children with cancer or other blood disorders will participate. Researchers …
Matched conditions: NON-MALIGNANT DISORDERS
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 26, 2026 05:51 UTC